bibliographic entry 5530267 [be/5530267]
https://w3id.org/oc/corpus/be/5530267

is a

• bibliographic reference

content

• Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Yeung DT et al. Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood 2013; 122: 515–522. PMID: 23704092

references

• https://w3id.org/oc/corpus/br/1736335